Sino Medical Sciences Technology In Total Assets
Sino Medical Sciences Technology In total assets. Based on the latest financial reports, Sino Medical Sciences Technology In (688108) holds total assets worth CN¥1.36 Billion CNY (≈ $198.69 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 688108 stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Sino Medical Sciences Technology In (2016–2025)
Total assets of Sino Medical Sciences Technology In from 2016 to 2025. This chart illustrates how Sino Medical Sciences Technology In's total assets have evolved over time, based on quarterly financial data. See 688108 live share price for real-time trading data and today's change.
Sino Medical Sciences Technology In - Asset Composition Analysis
Sino Medical Sciences Technology In Total Assets Breakdown (December 2025)
Sino Medical Sciences Technology In total assets breakdown as of December 2025. Sino Medical Sciences Technology In's total assets of CN¥1.36 Billion consist of 38.6% current assets and 61.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.4% |
| Accounts Receivable | CN¥25.14 Million | 1.9% |
| Inventory | CN¥88.79 Million | 6.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥584.95 Million | 43.3% |
| Goodwill | CN¥46.22 Million | 3.4% |
Asset Composition Trend (2016–2025)
This chart illustrates how Sino Medical Sciences Technology In's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Sino Medical Sciences Technology In's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sino Medical Sciences Technology In's current assets represent 38.6% of total assets in 2025, a decrease from 53.7% in 2016.
- Cash Position: Cash and equivalents constituted 29.4% of total assets in 2025, up from 15.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 26.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 43.3% of total assets.
Sino Medical Sciences Technology In Competitors by Total Assets
Key competitors of Sino Medical Sciences Technology In based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Memphasys Ltd
AU:MEM
|
Australia | AU$10.45 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
Sino Medical Sciences Technology In - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.66 | 2.39 | 6.38 |
| Quick Ratio | 2.26 | 1.92 | 5.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥356.42 Million | CN¥267.80 Million | CN¥392.23 Million |
Sino Medical Sciences Technology In - Advanced Valuation Insights
This section examines the relationship between Sino Medical Sciences Technology In's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.60 |
| Latest Market Cap to Assets Ratio | 0.63 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | CN¥1.35 Billion |
| Market Capitalization | $846.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sino Medical Sciences Technology In's assets below their book value (0.63x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sino Medical Sciences Technology In's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sino Medical Sciences Technology In (2016–2025)
The table below shows the annual total assets of Sino Medical Sciences Technology In from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.35 Billion ≈ $197.50 Million |
+3.78% |
| 2024-12-31 | CN¥1.30 Billion ≈ $190.31 Million |
+9.68% |
| 2023-12-31 | CN¥1.19 Billion ≈ $173.52 Million |
+11.07% |
| 2022-12-31 | CN¥1.07 Billion ≈ $156.23 Million |
-3.22% |
| 2021-12-31 | CN¥1.10 Billion ≈ $161.42 Million |
-9.40% |
| 2020-12-31 | CN¥1.22 Billion ≈ $178.16 Million |
+0.99% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.42 Million |
+49.56% |
| 2018-12-31 | CN¥806.10 Million ≈ $117.96 Million |
+13.48% |
| 2017-12-31 | CN¥710.33 Million ≈ $103.94 Million |
+152.95% |
| 2016-12-31 | CN¥280.81 Million ≈ $41.09 Million |
-- |
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Science… Read more